EUVIMEDEUVIMED entdecken
Open Access

Optical Coherence Tomography Biomarkers in Diabetic Macular Edema and Their Role in Predicting Visual Outcome After Ranibizumab or Triamcinolone Injection

Shanmugasundaram Palanisamy, Priyadarshini Mishra, Bhagabat Nayak, Bruttendu Moharana, Bijnya B Panda, Sucheta Parija, Mathan Kumar Ramasubbu

Cureus · 30.07.2026

DOI: 10.7759/cureus.113631 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cureus, erschienen am 30.07.2026. Verfasst von Shanmugasundaram Palanisamy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology, All India Institute of Medical Sciences, Bhubaneswar, Bhubaneswar, IND. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetic macular edema (DME) is the most common cause of defective vision in patients with diabetic retinopathy. With intravitreal injection being a treatment option, different forms of anti-vascular endothelial growth factor (anti-VEGF) and steroid injections are available. In order to choose the effective intravitreal injection based on the retinal changes in optical coherence tomography (OCT) biomarkers, analysis is crucial.

Aim

This study aimed to investigate the changes in OCT biomarkers after intravitreal injection of anti-VEGF (ranibizumab) or steroid (triamcinolone) in DME and to correlate them with visual outcome.

Methods

This prospective observational study included patients diagnosed with diabetic retinopathy with clinically significant macular edema (CSME). Best corrected visual acuity (BCVA) and OCT biomarkers were measured at baseline and after one month of intravitreal injection.

Results

A total of 58 eyes were included. There was a significant change in OCT parameters, central macular thickness (CMT), subretinal fluid (SRF) height, intraretinal cyst height, and hyperreflective foci (HRF), one month after a single intravitreal injection (p

Schlagwörter

Stichwörter der Autor:innen

biomarkersdiabetic macular edemadisorganization in inner retinal layersellipsoid zone integrityhyperreflective fociintravitreal injectionoct biomarkersranibizumabtriamcinolone

Autor:innen und Institutionen

  • Ophthalmology, All India Institute of Medical Sciences, Bhubaneswar, Bhubaneswar, IND.
  • Pharmacology, All India Institute of Medical Sciences, Bhubaneswar, Bhubaneswar, IND.

Zitieren

APA

Palanisamy, S., Mishra, P., Nayak, B., Moharana, B., Panda, B. B., Parija, S., & Ramasubbu, M. K. (2026). Optical Coherence Tomography Biomarkers in Diabetic Macular Edema and Their Role in Predicting Visual Outcome After Ranibizumab or Triamcinolone Injection. Cureus. https://doi.org/10.7759/cureus.113631

Vancouver

Palanisamy S, Mishra P, Nayak B, Moharana B, Panda BB, Parija S, et al. Optical Coherence Tomography Biomarkers in Diabetic Macular Edema and Their Role in Predicting Visual Outcome After Ranibizumab or Triamcinolone Injection. Cureus. 2026. doi:10.7759/cureus.113631

BibTeX
@article{Palanisamy2026,
  author = {Palanisamy, Shanmugasundaram and Mishra, Priyadarshini and Nayak, Bhagabat and Moharana, Bruttendu and Panda, Bijnya B and Parija, Sucheta and Ramasubbu, Mathan Kumar},
  title = {Optical Coherence Tomography Biomarkers in Diabetic Macular Edema and Their Role in Predicting Visual Outcome After Ranibizumab or Triamcinolone Injection},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.113631}
}
Kostenlos starten →